BioCentury | Dec 3, 2020
Product Development

Over 100 Phase III readouts from COVID-19 therapies possible by 2Q21: Data Byte

...III trials of hydroxychloroquine have been terminated. Four additional antiparasitic agents are being evaluated for COVID: ivermectin...
BioCentury | Jun 6, 2020
Product Development

Over 200 COVID-19 trials nearing completion should provide a busy summer of data readouts

...which are repurposed, are leading the therapeutic classes, beating out antiparasitics such as hydroxychloroquine and ivermectin...
BioCentury | May 3, 2019
Finance

Earnings on deck

...5/8 Post $0.18 $0.28 -36% Genmab A/S (CSE:GEN; Pink:GMXAY) 5/8 Post NA DKK 3.20 NA Perrigo...
BioCentury | Jan 23, 2019
Translation in Brief

Partners in Neglected Infections

...nematodes that depend on Wolbachia , the parasites' endosymbiont, for survival. Approved therapies such as ivermectin...
BioCentury | Aug 17, 2018
Company News

Perrigo to separate its generics business

...which could include a separation to shareholders, sale or merger -- to complete in 2H19. Perrigo...
...years. In June, FDA issued a letter to the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo...
...misbranding. Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO), Dublin, Ireland Business: Generics Jaime De Leon Merck & Co. Inc. Perrigo...
BioCentury | Jun 22, 2018
Company News

FDA cracks down on missing postmarket trial

...FDA determined the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO) has...
...is notable in that regard, that they're following up and threatening to do something." Elizabeth S. Eaton Perrigo...
BioCentury | Feb 20, 2018
Company News

Management tracks: Cell Medica, Iterum

...officer. He was group VP and head of patient engagement at Shire plc (LSE:SHP; NASDAQ:SHPG). Perrigo...
BioCentury | Sep 25, 2017
Company News

Management tracks: TapImmune, Camel-IDS, Arvinas

...Basi CSO. He was chief science and technology officer at Elan Corp. plc , which Perrigo...
BioCentury | Aug 18, 2017
Financial News

Vicarius raises $21.8M in series A

...Hasler will serve as Vicarius' CEO. He was COO at Elan Corp. plc , which Perrigo...
BioCentury | Aug 15, 2017
Financial News

Vicarius raises $21.8M in series A

...Hasler will serve as Vicarius' CEO. He was COO at Elan Corp. plc , which Perrigo...
Items per page:
1 - 10 of 116